Home
>
National Drug Code (NDC)
>
Moexipril Hydrochloride and Hydrochlorothiazide
Moexipril Hydrochloride and Hydrochlorothiazide - 0574-0135-01 - (Moexipril Hydrochloride and Hydrochlorothiazide)
Drug Information of Moexipril Hydrochloride and Hydrochlorothiazide
| Product NDC: | 0574-0135 |
| Proprietary Name: | Moexipril Hydrochloride and Hydrochlorothiazide |
| Non Proprietary Name: | Moexipril Hydrochloride and Hydrochlorothiazide |
| Active Ingredient(s): | 25; 15 mg/1; mg/1 & nbsp; Moexipril Hydrochloride and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Moexipril Hydrochloride and Hydrochlorothiazide
| Product NDC: | 0574-0135 |
| Labeler Name: | Paddock Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090096 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090701 |
Package Information of Moexipril Hydrochloride and Hydrochlorothiazide
| Package NDC: | 0574-0135-01 |
| Package Description: | 100 TABLET, COATED in 1 BOTTLE (0574-0135-01) |
NDC Information of Moexipril Hydrochloride and Hydrochlorothiazide
| NDC Code | 0574-0135-01 |
| Proprietary Name | Moexipril Hydrochloride and Hydrochlorothiazide |
| Package Description | 100 TABLET, COATED in 1 BOTTLE (0574-0135-01) |
| Product NDC | 0574-0135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Moexipril Hydrochloride and Hydrochlorothiazide |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | ANDA |
| Labeler Name | Paddock Laboratories, Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE |
| Strength Number | 25; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
